2021-06-08 Assigned to CYTEIR THERAPEUTICS, INC. reassignment CYTEIR
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …

First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
43502894&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

US9670196B2 - Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase
inhibitors - Google Patents US9670196B2 - Thiazole-substituted aminoheteroaryls as …

The invention provides certain thiazole-substituted amino heteroaryl compounds of the
Formula (I) or pharmaceuti cally acceptable salts thereof, wherein X, X2, X3, X4, Y', Y?, Y> …

WO2015051244A1 - Heterocyclic compounds and uses thereof - Google Patents
WO2015051244A1 - Heterocyclic compounds and uses thereof - Google Patents …

The invention provides certain thiazole-substituted amin opyridine compounds of the
Formula (I)(I) or pharmaceu tically acceptable salts thereof, wherein RRRRR RC, and the …

A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, eg
guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring …

WO2012151137A1 - Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors - Google
Patents WO2012151137A1 - Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors …

DEVSOMFAQLZNKR-RJRFIUFISA-N (Z)-3-[3-[3, 5-bis (trifluoromethyl) phenyl]-1, 2, 4-triazol-
1-yl]-N'-pyrazin-2-ylprop-2-enehydrazide Chemical group FC (F)(F) C1= CC (C (F)(F) F) …

The invention provides certain pyrazine-2-carboxamide compounds of the Formula (I) or
pharmaceutically accept able salts thereof, wherein A, B, and X are as defined herein. The …